Staged Diabetes Management

Staged Diabetes Management continues the five–decade tradition of the International Diabetes Center by providing clinical pathways that improve care practices. SDM uses evidence–based medicine to address the prominent issues of primary care diabetes management. It supplies practical solutions to the detection and treatment of diabetes, its complications and such new areas as the metabolic syndrome, pre–diabetes and type 2 diabetes in children. Completely revised and updated, the text reviews the fundamental basis of diabetes management and then addresses treatment of each type of diabetes and the major micro– and macrovascular complications. Written for primary care, it is organised in such a manner as to allow the clinician to learn about each distinctive type of diabetes as well as to see the areas of overlap. Issues range from classification, screening and detection to starting a therapy and long–term management of hypertension complicated by diabetes. Educational, nutritional and behavioural issues are also covered. Using DecisionPaths as a way to organise clinical decision–making, each chapter can stand alone, yet they are integrated (as is clinical practice). Each DecisionPath is structured so that therapies can be started, adjusted and maintained. Each decision point is clarified in the text along with the scientific basis for the decision. First written and published in 1999, the text reviews the fundamental basis of diabetes management and then addresses treatment of each type of diabetes and the major micro– and macrovascular complications. Written for primary care, the text is organized in such a manner as to allow the clinician to learn about each distinctive type of diabetes as well as to see the areas of overlap. Issues range from classification, screening and detection to starting a therapy and long–term management of hypertension complicated by diabetes. Educational, nutritional and behavioral issues are also covered. Using DecisionPaths as a way to organize clinical decision–making, each chapter can stand alone, yet they are integrated (as is clinical practice). Each DecisionPath is structured so that therapies can be started, adjusted and maintained. Each decision point is clarified in the text along with the scientific basis for the decision. Roger S. Mazze, PhD, Chief Academic Officer, International Diabetes Center, Vice President, Park Nicollet Institute. Director, World Health Organization Collaborating Center at International Diabetes Center and Clinical Professor of Family Practice and Community Health, University of Minnesota Medical School. Formerly, Professor of Biostatistics, Epidemiology and Community Health, and Executive Director and Co-Principal Investigator of the Diabetes Research and Training Center, Albert Einstein College of Medicine and Distinguished Visiting Scientist to the United States Centers for Disease Control. Past Co-Chairperson, American Diabetes Association Council on Health Care Delivery. Ellie S. Strock, RN, BC, ANP, CDE, Chief of Professional Services, International Diabetes Center, Vice President, Park Nicollet Institute. Chief Education Director, World Health Organization Collaborating Center at International Diabetes Center. Board Certified Adult Nurse Practitioner, Department of Endocrinology, Park Nicollet Health Services. Gregg D. Simonson, PhD, Director, Program Research and Implementation and Chief Research Officer, World Health Organization Collaborating Center at International Diabetes Center. Adjunct Assistant Professor, Department of Family Practice and Community Health, University of Minnesota Medical School. Formerly, Post-Doctoral Fellow, Juvenile Diabetes Foundation, Department of Pediatrics, University of Wisconsin. Richard M. Bergenstal, MD, Executive Director, International Diabetes Center and Clinical Professor of Medicine in Endocrinology, University of Minnesota Medical School. Consultant, Department of Endocrinology, Park Nicollet Health Services. Formerly, Assistant Professor of Medicine, University of Chicago. Past Member, National Board of Directors, American Diabetes Association. ROGER MAZZE; RICHARD M. BERGENSTAL; ROBERT CUDDIHY; ELLIE S. STROCK; AMY CRIEGO; ODED LANGER; GREGG SIMONSON; MAGGIE POWERS